Accueil » Hepatocyte Growth Factor Receptor (MET/c-MET) | ABMIUM

ABMIUM target intelligence

MET

MET proto-oncogene, receptor tyrosine kinase

MET identifies MET proto-oncogene, receptor tyrosine kinase in Homo sapiens (Human). This target record connects NCBI Gene 4233, UniProtKB P08581 and related ABMIUM catalogue products.

Read full target overview
OrganismMultiple species; representative: Homo sapiens (Human) NCBI Gene4233 UniProtP08581

MET products

Need help?Ask a scientist
Loading… products
Anti-Met (c-Met) Antibody Picoband® Boster Bio
Boster BioABMIUM Verified™

Anticorps anti-Met (c-Met) Picoband®

SKU: ABM20652-1Anticorps primaires
Target
Récepteur du facteur de croissance des hépatocytes
Reactivity
Humain,Rat
Applications
ELISA, Cytométrie en flux, IHC, IHC-P, WB
Host
Lapin
From£278.80£328.00 Save 15%
Available to order
Choose options
Comparing

Research context & evidence

About MET

Target information is kept separate from product-level validation so you can review the biology and the reagent evidence independently.

Biology

Biological function

Hepatocyte growth factor receptor (MET; c-MET/HGFR) is a receptor tyrosine kinase activated by hepatocyte growth factor. MET signalling regulates cell survival, proliferation, motility, morphogenesis and invasive growth.

Experimental context

Research context

Hepatocyte growth factor receptor (MET/c-MET) is studied in HGF-MET signalling, epithelial morphogenesis, cell migration and invasion, tissue repair and cancer biology. Use the catalogue filters below to compare ABMIUM MET reagents and confirm product-level suitability before use.

Identifiers

Alternative names

Names used across publications, databases and supplier catalogues.

Hepatocyte growth factor receptorHGFRc MetAUTS9DA11DFNB97RCCP2HGFPar4